Main criteria and risk factors for the development of recurrent endometriosis

Senina D.N., Chuprynin V.D., Buralkina N.A., Chursin V.V., Smolnova T.Yu., Davidyan L.Yu., Abosov A.S.

1) I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russia; 2) Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Moscow, Russia; 3) Ulyanovsk State University, Ulyanovsk, Russia
Objective: To analyze the data available in the current literature on the recurrence of different forms of endometriosis and to identify the main criteria and risk factors for the development of a relapse of the disease. The review article includes the data published by foreign and Russian authors in the Pubmed, UpToDate, and eLibrary databases on the keywords "endometriosis", "deep infiltrating endometriosis", and "recurrent endometriosis". Endometriosis is observed in 10% of reproductive-aged women and ranks third among gynecological diseases. The literature review focuses on risk factors for recurrent endometriosis. The term “recurrent endometriosis” is non-uniform and ambiguous; different studies describe various parameters of recurrent disease. This concept is used in different sources of literature in different ways: as recurrent pain, as the detection of new lesions by pelvic ultrasound or MRI, as a repeated increase in CA-125 levels, or as a surgical finding of new endometrioid implants during surgery unassociated with endometriosis.
Conclusion: At the moment, there are no unified clinical and molecular criteria for recurrent endometriosis. The lack of understanding of risk factors for recurrent endometriosis cannot build a unified strategy for early diagnosis, timely therapy and surgical treatment.

Keywords

endometriosis
common forms of endometriosis
deep infiltrating endometriosis
recurrent endometriosis
recurrent ovarian endometrioid cysts

References

  1. Schenken R.S., Barbieri R.L., Eckler K. Endometriosis: pathogenesis, clinical features, and diagnosis. UpToDate; 2019.
  2. Dunselman G.A., Vermeulen N., Becker C., Calhaz-Jorge C., D'Hooghe T.,De Bie B. et al.; European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Hum. Reprod. 2014; 29(3): 400-12. https://dx.doi.org/10.1093/humrep/det457.
  3. Nisolle M., Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil. Steril. 1997; 68(4): 585-96. https://dx.doi.org/10.1016/s0015-0282(97)00191-x.
  4. Smolarz B., Szyłło K., Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (Review of Literature). Int. J. Mol. Sci. 2022; 22(19): 10554. https://dx.doi.org/10.3390/ijms221910554.
  5. Donnez J., Pirard C., Smets M., Jadoul P., Squifflet J. Surgical management of endometriosis. Best Pract. Res. Clin. Obstet. Gynaecol. 2004; 18(2): 329-48. https://dx.doi.org/10.1016/j.bpobgyn.2014.03.004.
  6. Guo S.-W., Martin D.C. The perioperative period: a critical yet neglected time window for reducing the recurrence risk of endometriosis? Hum. Reprod. 2019; 34(10): 1858-65. https://dx.doi.org/10.1093/humrep/dez187.
  7. Guo S.-W. Recurrence of endometriosis and its control. Hum. Reprod. Update. 2009; 15(4): 441-61. https://dx.doi.org/10.1093/humupd/dmp007.
  8. Lee D.Y., Lee J.Y., Seo J.W., Yoon B.K., Choi D. Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis. Arch. Gynecol. Obstet. 2016; 294(6): 1257-63.https://dx.doi.org/10.1007/s00404-016-4184-9.
  9. Yang F., Liu B., Xu L., Liu H. Age at surgery and recurrence of ovarian endometrioma after conservative surgery: a meta-analysis including 3125 patients. Arch. Gynecol. Obstet. 2020; 302(1): 23-30.https://dx.doi.org/10.1007/s00404-020-05586-3.
  10. Parazzini F., Bertulessi C., Pasini A., Rosati M., Di Stefano F., Shonauer S. et al. Determinants of short term recurrence rate of endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2015; 121(2): 16-9. https://dx.doi.org/10.1016/j.ejogrb.2004.11.033.
  11. Zakhari A., Delpero E., McKeown S., Tomlinson G., Bougie O., Murji A. Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis. Hum. Reprod. Update. 2021; 27(1): 96-107. https://dx.doi.org/10.1093.
  12. Saleh A., Tulandi T. Reoperation after laparoscopic treatment of ovarian endometriomas by excision and by fenestration. Ferti.l Steril. 1999; 72(2): 322-4. https://dx.doi.org/10.1016/s0015-0282(99)00243-5.
  13. Porpora M.G., Pallante D., Ferro A., Crisafi B., Bellati F., Benedetti Panici P. Pain and ovarian endometrioma recurrence after laparoscopic treatment of endometriosis: a long-term prospective study. Fertil. Steril. 2010; 93(3): 716-21. https://dx.doi.org/10.1016/j.fertnstert.2008.10.018.
  14. Nowak-Psiorz .I, Ciećwież S.M., Brodowska A., Starczewski A. Treatment of ovarian endometrial cysts in the context of recurrence and fertility. Adv. Clin. Exp. Med. 2019; 28(3): 407-13. https://dx.doi.org/10.17219/acem/90767.
  15. Ершова И.Ю., Краснопольская К.В., Попов А.А., Краснопольская И.В., Коваль А.А. Состояние овариального резерва у пациенток с бесплодием после операций по поводу двусторонних эндометриоидных кист яичников. Проблемы репродукции. 2021; 27(4): 56-63. [Yershova I.Yu., Krasnopolskaya K.V., Popov A.A., Krasnopolskaya I.V., Koval A.A. The ovarian reserve in infertile patients after bilateral endometrioid ovarian cysts removal with and without recurrence. Russian Journal of Human Reproduction. 2021; 27(4): 56-63. (in Russian)].
  16. Chen I., Veth V.B., Choudhry A.J., Murji A., Zakhari A., Black A.Y. et al. Pre- and postsurgical medical therapy for endometriosis surgery. Cochrane Database Syst. Rev. 2020; 11(11): CD003678. https://dx.doi.org/10.1002/14651858.CD003678.pub3.
  17. Leeners B., Damaso F., Ochsenbein-Kölble N., Farquhar C. The effect of pregnancy on endometriosis—facts or fiction? Hum. Reprod. Update. 2018; 24(3): 290-9. https://dx.doi.org/10.1093/humupd/dmy004.
  18. Джобава Э.М., Мандрыкина Ж.А., Логинова К.Б., Доброхотова Ю.Э. Дисменорея. Этиопатогенез, дифференциальная диагностика и терапия в практике современного акушера-гинеколога. РМЖ. Мать и дитя. 2012; 20(1): 28-34. [Dzhobava E.M., Mandrykina Zh.A., Loginova K.B., Dobrokhotova Yu.E. Dysmenorrhea. Etiopathogenesis, differential diagnosis and therapy in the practice of a modern obstetrician-gynecologist. Russian Journal of Woman and Child Health. 2012;1:28-34 (in Russian)].
  19. Scioscia M., Bruni F., Ceccaroni M., Steinkasserer M., Stepniewska A.,Minelli L. Distribution of endometriotic lesions in endometriosis stage IV supports the menstrual reflux theory and requires specific preoperative assessment and therapy. Acta Obstet. Gynecol. Scand. 2011; 90(2): 136-9. https://dx.doi.org/10.1111/j.1600-0412.2010.01008.x.21.
  20. Matorras R., Elorriaga M.A., Pijoan J.I., Ramo’n O., Rodriguez Escu- dero F.J. Recurrence of endometriosis in women with bilateral ad- nexectomy (with or without total hysterectomy) who received hor- mone replacement therapy. Fertil. Steril. 2012; 77(2): 303-8. https://dx.doi.org/10.1016/s0015-0282(01)02981-8.
  21. Адамян Л.В., Арсланян К.Н., Харченко Э.И., Логинова О.Н. Современные направления в медикаментозном лечении эндометриоза. Проблемы репродукции. 2019; 25(6): 58-66. https://dx.doi.org/10.17116/repro20192506158. [Adamyan L.V., Arslanyan K.N., Kharchenko E.I., Loginova O.N. Modern trends in the treatment of endometriosis. Russian Journal of Human Reproduction. 2019;25(6):5866. (in Russian)].https://dx.doi.org/10.17116/repro20192506158.
  22. Муфтайдинова Ш.К., Файзуллин Л.З., Чупрынин В.Д., Русейкин Н.С., Смольнова Т.Ю., Буралкина Н.А. Клинико-диагностические аспекты глубокого инфильтративного эндометриоза (диагностика, лечение, рецидивы). Гинекология. 2021; 23(4): 307-13. [Muftaidinova Sh.K., Faizullin L.Z., Chuprynin V.D., Ruseikin N.S., Smolnova T.Iu., Buralkina N.A. Clinical and diagnostic aspects of deep infiltrative endometriosis (diagnosis, treatment, recurrence). Gynecology. 2021; 23(4): 307-13. (in Russian)].
  23. Maillard C., Cherif Alami Z., Squifflet J.L., Luyckx M., Jadoul P., Thomas V., Wyns C. Diagnosis and treatment of vulvo-perineal endometriosis: a systematic review. Front. Surg. 2021; 8: 637180. https://dx.doi.org,/10.3389/fsurg.2021.637180.
  24. Biacchiardi C.P., Piane L.D., Camanni M., Deltetto F., Delpiano E.M., Marchino G.L. et al. Laparoscopic stripping of endometriomas negatively affects ovarian follicular reserve even if performed by experienced surgeons. Reprod. Biomed. Online. 2011; 23(6): 740-6. https://dx.doi.org/10.1016/j.rbmo.2011.07.014.
  25. Busacca M., Chiaffarino F., Candiani M., Vignali M., Bertulessi C., Oggioni G., Parazzini F. Determinants of long-term clinically detected recurrence rates of deep, ovarian, and pelvic endometriosis. Am. J. Obstet. Gynecol. 2016; 195(2): 426-32. https://dx.doi.org/10.1016/j.ajog.2006.01.078.
  26. Nezhat C., Hajhosseini B., King L.P. Laparoscopic management of bowel endometriosis: predictors of severe disease and recurrence. JSLS. 2011; 15(4): 431-8. https://dx.doi.org/10.4293/108680811X13176785203752.

Received 26.07.2022

Accepted 11.10.2022

About the Authors

Daria N. Senina, PhD student, Surgical Department, I.M. Secenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University),
119992, Russia, Moscow, Trubetskaya str., 2; Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology,
Ministry of Health of Russia, 117997, Russia, Moscow, Oparin str., 4, +7(904)189-30-63, seninadasha1995@gmail.com
Vladimir D. Chuprynin, PhD, Head of the Surgical Department, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Oparin str., 4, +7(985)465-28-08, v_chuprynin@oparina4.ru
Natalya A. Buralkina, Dr. Med. Sci., Senior Researcher at Surgical Department, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Oparin str., 4, +7(926)405-62-83, natalyaburalkina@yandex.ru
Vyacheslav V. Chursin, surgeon at the Department of General Surgery, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Oparin str., 4, +7(926)971-21-03, v_chursin@oparina4.ru
Tatyana Yu. Smolnova, Dr. Med. Sci., Senior Reseacher at the Surgery Department, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Oparin str., 4, +7(926)310-80-90, smoltat@list.ru
Liana Yu. Davidyan, Dr. Med. Sci., Professor of the Faculty of postgraduate medical and pharmaceutical education, Ulyanovsk State University,
432017, Russia, Ulyanovsk, Lva Tolstogo str., 42, +7(927)631-49-68, dliana2009@mail.ru
Аzizbek S. o’g’li Abosov, resident, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Oparin str., 4, abosovazizbek11@gmail.com

Authors’ contributions: Senina D.N. – information collection, literature data analysis, review formation, writing the text; Chuprynin V.D. – review formation, foreign literature analysis; Buralkina N.A. – review formation, foreign literature analysis, review article editing; Chursin V.V. – review formation, Russian literature analysis, review article editing; Smolnova T.Yu. – editing; Davidyan L.Yu. – review article editing; Abosov A.S. – assistance in preparing the article, as required.
Conflicts of interest: The authors declare that there are no conflicts of interest.
Funding: The source of funding is the state assignment "Comprehensive approach to diagnosing and choosing a surgical treatment option for reproductive-aged patients with deep infiltrating endometriosis".
For citation: Senina D.N., Chuprynin V.D., Buralkina N.A., Chursin V.V., Smolnova T.Yu., Davidyan L.Yu., Abosov A.S. Main criteria and risk factors for the development
of recurrent endometriosis.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2022; 10: 22-26 (in Russian)
https://dx.doi.org/10.18565/aig.2022.10.22-26

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.